Hochschulschrift
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
- Alternative title
-
Beteiligung zellulärer Faktoren an der Permissivität von Wirtszellen in Unterstützung der onkolytischen Vaccinia Virus Replikation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Würzburg, Universität Würzburg, Dissertation, 2012
- Keyword
-
Vaccinia-Virus
Microarray
Melanom
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2012
- Creator
- Contributor
-
Szalay, Aladár
- URN
-
urn:nbn:de:bvb:20-opus-85392
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Reinboth, Jennifer
- Szalay, Aladár
- Universität Würzburg
Time of origin
- 2012
Other Objects (12)
Cellular factors contributing to host cell permissiveness in support of oncolytic vaccinia virus replication
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
Biogenesis of vaccinia virus cytoplasmic DNA replication sites and their sub-cellular localization
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Cellular factors contributing to host cell permissiveness in support of oncolytic vaccinia virus replication
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
Biogenesis of vaccinia virus cytoplasmic DNA replication sites and their sub-cellular localization
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Cellular factors contributing to host cell permissiveness in support of oncolytic vaccinia virus replication
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
Biogenesis of vaccinia virus cytoplasmic DNA replication sites and their sub-cellular localization
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma